Form EFFECT Omega Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 25, 2025 |
| Accession Number: | 0001193125-25-060215 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- As Global Demand for Electric Vehicle Infrastructure Accelerates, ELEKTROS Advances Its Strategic Vision for High-Speed Charging Solutions
- Pat Mercuri’s Mortgage Marketing Conference Presentation Highlights the Growing Demand for Data-Driven Direct Mail Strategies
- Chinese Legal Expert Calls for Stronger Rule of Law to Advance China-Europe ESG Cooperation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
